Lazard Asset Management
DNLI icon

Lazard Asset Management’s Denali Therapeutics DNLI Stock Holding History

Lazard Asset Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,410
Closed -$90K – 2280
2024
Q1 		$90K Hold
4,410
– – ﹤0.01% 1573
2023
Q4 		$94K Sell
4,410
-6,451
-59% -$128K ﹤0.01% 1681
2023
Q3 		$223K Buy
10,861
+5,916
+120% +$150K ﹤0.01% 1354
2023
Q2 		$145K Buy
4,945
+2,025
+69% +$56.9K ﹤0.01% 1441
2023
Q1 		$67K Sell
2,920
-2,433
-45% -$67K ﹤0.01% 1687
2022
Q4 		$148K Hold
5,353
– – ﹤0.01% 1372
2022
Q3 		$164K Hold
5,353
– – ﹤0.01% 1316
2022
Q2 		$157K Buy
+5,353
New +$140K ﹤0.01% 1348
2021
Q4 		– Sell
-1,186
Closed -$59K – 2322
2021
Q3 		$59K Buy
+1,186
New +$66.8K ﹤0.01% 1601
2021
Q2 		– Sell
-833
Closed -$47K – 1985
2021
Q1 		$47K Buy
+833
New +$55.8K ﹤0.01% 1453
2020
Q1 		– Sell
-1,073
Closed -$18K – 1611
2019
Q4 		$18K Buy
+1,073
New +$17.9K ﹤0.01% 1254

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return